Crispr Therapeutics $CRSP has been consolidating since it pushed to almost $74 a share. Price retreated sharply during the correction, falling back to almost $45 a share. CRSP Daily Chart(click to enlarge)Resistance Ahead:- After falling to about $45.25 a share, price began to recover. - In the last couple of weeks price has been percolating, coming up to $59.00 during the 9/4 session before retreating.- We can say that the attempt to break higher failed at a recognizable resistance from a falling trendline.- So, price action here almost showed strong prospect of continuing the bullish trend.- Now, if price can hold above $52, we should still anticipate a bullish breakout to test the $60-$61 area. - Also note that if the market is still in bearish correction mode, the RSI should not stay above 60 and should retreat below it very soon.- If this happens, and then price also falls below $52, the bullish attempt can be considered a failure, and we should anticipate more pain, with the $40 in sight.